• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthFDA

The FDA Now Requires Stronger Warning Labels for Opioid Drugs

By
Reuters
Down Arrow Button Icon
By
Reuters
Down Arrow Button Icon
September 1, 2016, 10:36 AM ET
New England Towns Struggle With Opioid And Heroin Epidemic
Oxycodone pain pills prescribed for a patient with chronic pain lie on display on March 23, 2016 in Norwich, CT. Communities nationwide are struggling with the unprecidented opioid pain pill and heroin addiction epidemic. On March 15, the U.S. Centers for Disease Control (CDC), announced guidelines for doctors to reduce the amount of opioid painkillers prescribed, in an effort to curb the epidemic. The CDC estimates that most new heroin addicts first became hooked on prescription pain medication before graduating to heroin, which is stronger and cheaper.Photograph by John Moore—Getty Images

The U.S. Food and Drug Administration on Wednesday strengthened warnings about the danger of combining opioid painkillers or cough medicines containing opioids with benzodiazepines, a common class of sedatives.

The agency is requiring that black box warnings, the strongest available, be added to nearly 400 products, alerting doctors and patients that combining opioids and benzodiazepines can cause extreme sleepiness, slowed breathing, coma, and death.

The agency said the move is part of a broad action plan to reduce the number of deaths from opioid painkiller abuse.

“It is nothing short of a public health crisis when you see a substantial increase of avoidable overdose and death related to two widely used drug classes being taken together,” said FDA commissioner Robert Califf.

 

“We implore health care professionals to heed these new warnings,” he added.

Opioids include oxycodone, hydrocodone, fentanyl, and morphine, and are sold under such brand names as OxyContin, Percocet, Vicodin, and Actiq. Benzodiazepines include such drugs as alprazolam, clonazepam, and lorazepam, sold under the brands Xanax, Klonopin, and Ativan.

The move comes as prescriptions for both opioids and benzodiazepines has been increasing. Between 2004 and 2011 the number of patients who were prescribed an opioid and a benzodiazepine increased by 41 percent, the agency said, an increase of more than 2.5 million in opioid pain patients also receiving benzodiazepines.

The number of overdose deaths involving both classes of deaths nearly tripled over the same period, the FDA said.

Warnings about the interaction of both classes of drugs have been in existence for years, but are insufficient, the agency said. The current move strengthens them and “alerts all kinds of people who might otherwise have missed the message,” Califf said on a call with reporters.

The FDA’s action comes six months after city and state health directors, led by Baltimore City Health Commissioner Leana Wen, petitioned the FDA to require boxed warnings on the drugs.

Speaking on the call, Dr. Wen thanked the FDA for “acting so swiftly to our petition.”

Every day in the U.S., 44 people die as a result of prescription opioid overdoses. Wen said roughly one in three unintentional overdose deaths from opioids also involves benzodiazepines.

The reason, she said, is that prescribing opioids and benzodiazepines together has long been the medical norm. Over the years prescriptions of both have soared, resulting in the current epidemic.

About the Author
By Reuters
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

Johnson
PoliticsCongress
Republican leaders powerless to stop a January vote on healthcare after moderates defect on ACA subsidies
By Joey Cappelletti and The Associated PressDecember 18, 2025
8 hours ago
Simple App as best intermittent fasting app
HealthWeight Loss
The Best Intermittent Fasting Apps of 2025: From Nutrition Experts
By Christina SnyderDecember 18, 2025
11 hours ago
Noom as best weight loss program
HealthWeight Loss
Best Weight Loss programs of 2025: Expert Tested
By Christina SnyderDecember 18, 2025
13 hours ago
social epidemic
HealthLoneliness
25 years after a Harvard professor told America it was ‘bowling alone,’ the loneliness epidemic is starker than ever
By Peter Smith and The Associated PressDecember 18, 2025
15 hours ago
SuccessMillionaires
Tech CEO Bryan Johnson says he’ll make humans immortal by 2039—first he just needs to sort out ‘buggy’ issues like ‘mistakenly causing cancer’
By Orianna Rosa RoyleDecember 17, 2025
2 days ago
Johnson
PoliticsHealth Insurance
Vulnerable Republican blasts choice to send health insurance spiking as ‘political malpractice’
By Kevin Freking, Lisa Mascaro and The Associated PressDecember 16, 2025
2 days ago

Most Popular

placeholder alt text
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By Nick LichtenbergDecember 17, 2025
2 days ago
placeholder alt text
C-Suite
Red Lobster CEO Damola Adamolekun says the key to being a better leader is being a better person: ‘Leadership is self-improvement’
By Sydney LakeDecember 17, 2025
2 days ago
placeholder alt text
AI
'Robots are going to be amongst us': Qualcomm exec says buckle up for the next 5 years. Your car is going to be the first shoe to drop
By Nino PaoliDecember 17, 2025
2 days ago
placeholder alt text
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career advice for navigating the market: ‘You've got to make things happen for yourself’
By Preston ForeDecember 16, 2025
3 days ago
placeholder alt text
Success
Britain’s defense chief calls on Gen Z grads leaving university to skip corporate jobs and join the military as war with Russia becomes a growing risk
By Emma BurleighDecember 17, 2025
2 days ago
placeholder alt text
Future of Work
LinkedIn CEO says it's 'outdated' to have a five-year career plan: It's a 'little bit foolish' considering the pace AI is changing the workplace
By Sydney LakeDecember 18, 2025
16 hours ago